Mariner’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Mariner’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,390	Closed	-$18.4K	–	3042
2023 Q2	$18.4K	Hold	2,390	–	–	﹤0.01%	2782
2023 Q1	$23K	Sell	2,390 -3,057	-56%	-$23.6K	﹤0.01%	2720
2022 Q4	$18K	Sell	5,447 -500	-8%	-$2.93K	﹤0.01%	2692
2022 Q3	$33K	Buy	+5,947	New	+$58.9K	﹤0.01%	2356

Other funds holding PHXM

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mariner's PHXM Position: Q3 2023 in Review

Mariner sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q3 2023, closing a stake of 2,390 shares — an estimated $18.4K sold.

Mariner first reported a position in PHXM in Q3 2022 and held it in 4 quarters. The position peaked at $33K in Q3 2022. 3 funds tracked by Wall St. Rank hold PHXM as of Q3 2023.

Mariner reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Mariner sold 2,390 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q3 2023, an estimated $18.4K.
Mariner first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q3 2022 and held it in 4 quarters.
Mariner's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $33K in Q3 2022.
3 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q3 2023.

Based on Mariner's 13F filing for Q3 2023, filed 13 Nov 2023.